Sensata Technologies Holding plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Sensata Technologies Holding plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,202	3,307	3,522	3,451	3,046	3,821	4,029	4,054	3,933	3,705
Cost of revenue	2,084	2,139	2,267	2,267	2,119	2,542	2,712	2,793	2,777	2,620
Gross profit	1,118	1,168	1,255	1,183	927	1,278	1,317	1,261	1,156	1,084
Research and development	127	130	147	148	131	159	189	179	169	134
Selling, general and administrative	294	302	306	281	295	337	371	351	392	356
Operating income	492	556	710	557	338	633	670	182	149	238
Interest expense						183	196	182	156	149
Interest income						3.29	16.7	31.3	16.2	19.1
Other non-operating income	0.17	0.08	0.89	-0.67	-4.46	4.63	8.73	15.8	0.4	2.4
Pre-tax income	321	402	526	390	166	414	397	17.8	-11.8	123
Income tax	59	-5.92	-72.6	108	1.36	50.3	86	21.8	-140	92
Net income	262	408	599	283	164	364	311	-3.9	129	31.3
EBITDA	801	826	956	816	593	892	951	489	462	494
EPS, basic	1.54	2.39	3.55	1.76	1.04	2.30	2.00	-0.03	0.85	0.21
EPS, diluted	1.53	2.37	3.53	1.75	1.04	2.28	1.99	-0.03	0.85	0.21
Shares, basic (weighted)	171	171	169	161	157	158	155	152	150	147
Shares, diluted (weighted)	171	172	170	162	158	159	156	152	151	147
Dividend per share							0.33

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	351	753	730	774	1,862	1,709	1,226	508	594	573
Receivables	500	557	582	558	577	653	742	744	660	657
Inventory	390	446	492	507	451	588	645	713	615	618
Other current assets	100	92.5	113	127	90.3	126	162	137	159	146
Total current assets	1,341	1,848	1,917	1,966	2,980	3,077	2,775	2,102	2,027	1,994
Property, plant and equipment	724	750	787	831	804	821	841	886	822	777
Lease right-of-use assets				55.3	50	44.1	42.8	40.2	37.8	51.7
Goodwill	3,005	3,005	3,081	3,094	3,111	3,502	3,911	3,543	3,384	3,158
Intangible assets	1,075	920	897	771	692	947	1,000	884	493	412
Other non-current assets	73.9	84.6	86.9	152	173	162	129	135	130	134
Total assets	6,241	6,642	6,798	6,835	7,844	8,614	8,756	7,681	7,143	6,752
Accounts payable	299	323	380	377	394	459	532	482	362	413
Accrued liabilities	246	260	218	216	325	344	347	307	317	343
Short-term debt	9.9	9.8	9.7	4.63	757	4.63	255	0
Total current liabilities	583	629	640	635	1,495	836	1,179	824	711	775
Long-term debt	3,227	3,226	3,220	3,220	3,214	4,215	3,959	3,374	3,176	2,829
Lease liabilities				45.5	43.3	35.7	32.7	29.3	44.9	57.1
Other non-current liabilities	29.2	33.6	39.3	90.2	94	63.2	82.1	66.8	80.8	77.8
Total liabilities	4,299	4,296	4,189	4,261	5,139	5,519	5,645	4,685	4,253	3,966
Total debt	3,236	3,236	3,229	3,225	3,968	4,251	4,247	3,400	3,200	2,846
Paid-in capital	1,643	1,663	1,691	1,725	1,760	1,812	1,866	1,902	1,873	1,898
Retained earnings	637	1,032	1,341	1,616	1,778	2,132	2,383	2,296	2,340	2,296
Treasury stock	-307	-288	-399	-749	-785	-832	-1,125	-1,213	-1,282	-1,403
Other comprehensive income	-34.1	-63.2	-26.2	-20.5	-49.5	-19.6	-16.3	9.96	-42.5	-7.4
Shareholders' equity	1,942	2,346	2,608	2,574	2,705	3,095	3,111	2,996	2,890	2,785
Total equity	1,942	2,346	2,608	2,574	2,705	3,095	3,111	2,996	2,890	2,785
Total liabilities and equity	6,241	6,642	6,798	6,835	7,844	8,614	8,756	7,681	7,143	6,752
Shares outstanding	171	171

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	262	408	599	283	164	364	311	-3.9	129	31.3
Depreciation and amortization	308	270	245	259	255	259	281	307	313	256
Stock-based compensation	17.4	19.8	23.8	18.8	19.1	25.7	31.8	30	38.5	25
Deferred income tax	8.34	-56.8	-144	27.6	-44.9	-5.27	-0.78	-54.2	-233	-0.2
Change in inventory	-37.5	-57.1	-55.4	-10.9	58.4	-120	-44.4	-70.2	16.2	-14.3
Change in payables	-21.4	23.8	48.4	-34.6	90.5	35.3	40.9	-80.7	-110	56.7
Cash from operations	522	558	621	620	560	554	461	457	552	622
Capital expenditures	-130	-145	-160	-161	-107	-144	-150	-185	-159	-131
Acquisitions	4.69	0	-228	-32.5	-64.4	-736	-632	0	0
Purchases of investments	-50	0	0	-9.95	-23	-5.53	-7.98	-0.39
Cash from investing	-175	-141	-238	-209	-182	-882	-591	-165	-19.2	-95.8
Debt issued	0	928	0	450	1,150	1,002	500	0	500	0
Share buybacks	0	0	-399	-350	-35.2	-47.8	-292	-88.4	-68.9	-121
Dividends paid					0	0	-51.1	-71.5	-72.2	-70.4
Cash from financing	-338	-15.3	-406	-366	710	175	-353	-1,017	-443	-551
Exchange rate effect						0	0	7.5	-4	4.4
Net change in cash	9.17	402	-23.3	44.3	1,088	-153	-483	-717	85.6	-20.6
Free cash flow	391	413	461	458	453	410	311	272	393	490
Interest paid	156	164	163	170	164	189	189	187	148	157
Income taxes paid	43.2	48.5	72.9	61	65.8	66.6	68.8	95.5	92.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $42.19 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	29.5%	Gross profit / revenue.
Operating margin	7.5%	Operating income / revenue.
EBITDA margin	13.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.6%	Pre-tax income / revenue.
Net margin	2.4%	Net income / revenue.
FCF margin	15.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.4%	Cash from operations / revenue.
Effective tax rate	48.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	3.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.4%	Net income / average total assets.
Return on invested capital (ROIC)	2.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	3.4%	Research and development expense / revenue.
SG&A / revenue	9.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.0%	Capital expenditures / revenue.
D&A / revenue	6.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-6.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-6.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	59.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-29.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-6.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	6.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-19.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-3.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-75.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-53.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-28.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-75.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-52.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-27.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	12.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	10.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	24.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	16.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	1.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-3.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-8.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-3.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.29x	Current assets / current liabilities.
Quick ratio	1.40x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.49x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.82x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.8%	Total debt / total assets.
Liabilities / assets	55.1%	Total liabilities / total assets.
Net debt	$2.02B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.86x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.02x	Operating income / interest expense.
Working capital	$1.05B	Current assets - current liabilities.
Goodwill and intangibles / assets	53.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$580.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.57x	Revenue / average total assets.
Fixed asset turnover	4.97x	Revenue / average property, plant and equipment.
Inventory turnover	4.60x	Cost of revenue / average inventory.
Days inventory	79 days	365 x average inventory / cost of revenue.
Receivables turnover	5.12x	Revenue / average receivables.
Days sales outstanding	71 days	365 x average receivables / revenue.
Days payables	65 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	86 days	Days inventory + days sales outstanding - days payables.
FCF conversion	644.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.61	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$25.73	Revenue / diluted weighted shares.
FCF per share	$3.95	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.73	Cash from operations / diluted weighted shares.
Book value per share	$20.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.96	Tangible book value / shares outstanding.
Cash per share	$2.75	(Cash + short-term investments) / shares outstanding.
Payout ratio	77.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	12.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	4.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$6.14B	Share price x shares outstanding.
Enterprise value	$8.16B	Market cap + total debt - cash - short-term investments.
P/E	68.3x	Market cap / net income. Only when net income is positive.
P/S	1.63x	Market cap / revenue.
P/B	2.07x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.85x	Market cap / cash from operations, when positive.
EV/Sales	2.16x	Enterprise value / revenue.
EV/EBIT	28.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.4%	Free cash flow / market cap.
Earnings yield	1.5%	Net income / market cap (the inverse of P/E).
Dividend yield	1.1%	Dividends paid over the period / market cap.
Shareholder yield	1.5%	(Dividends paid + share buybacks) / market cap.

What was Sensata Technologies Holding plc's revenue in fiscal 2025?

Sensata Technologies Holding plc reported revenue of $3.70B for fiscal 2025, 5.8% lower than the year before.

Was Sensata Technologies Holding plc profitable in fiscal 2025?

Yes. Net income was $31.3M, a net margin of 0.8%.

How much free cash flow did Sensata Technologies Holding plc generate in fiscal 2025?

Cash from operations of $621.5M minus capital expenditures of $131.2M left free cash flow of $490.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Sensata Technologies Holding plc